ClinicalTrials.govpublic full text
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
anaplastic oligodendroglioma, astrocytoma, idh-mutant, grade 3, astrocytoma, idh-mutant, grade 4, diffuse astrocytoma, glioblastoma, idh-wildtype, malignant glioma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 146476
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.